logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Shall, Larry, Dr.
    Born in January 1955
    Individual (5 offsprings)
    Officer
    2013-04-29 ~ now
    OF - Director → CIF 0
    Dr. Larry Shall
    Born in January 1955
    Individual (5 offsprings)
    Person with significant control
    2016-05-02 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

SHALL DERMATOLOGY LIMITED

Period: 2013-04-29 ~ now
Company number: 08508513
Registered name
SHALL DERMATOLOGY LIMITED - now
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Property, Plant & Equipment
608 GBP2025-03-31
1,454 GBP2024-03-31
Fixed Assets - Investments
857,667 GBP2025-03-31
845,301 GBP2024-03-31
Fixed Assets
858,275 GBP2025-03-31
846,755 GBP2024-03-31
Debtors
239,405 GBP2025-03-31
60,878 GBP2024-03-31
Cash at bank and in hand
166,917 GBP2025-03-31
262,880 GBP2024-03-31
Current Assets
406,322 GBP2025-03-31
323,758 GBP2024-03-31
Net Current Assets/Liabilities
367,509 GBP2025-03-31
276,630 GBP2024-03-31
Total Assets Less Current Liabilities
1,225,784 GBP2025-03-31
1,123,385 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
Retained earnings (accumulated losses)
1,225,684 GBP2025-03-31
1,123,285 GBP2024-03-31
Equity
1,225,784 GBP2025-03-31
1,123,385 GBP2024-03-31
Average Number of Employees
52024-04-01 ~ 2025-03-31
52023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
15,237 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
14,629 GBP2025-03-31
13,783 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
846 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
608 GBP2025-03-31
1,454 GBP2024-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
46,935 GBP2025-03-31
Current, Amounts falling due within one year
52,735 GBP2024-03-31
Other Debtors
Amounts falling due within one year, Current
192,470 GBP2025-03-31
Current, Amounts falling due within one year
8,143 GBP2024-03-31
Debtors
Amounts falling due within one year, Current
239,405 GBP2025-03-31
Current, Amounts falling due within one year
60,878 GBP2024-03-31
Other Taxation & Social Security Payable
Current
32,755 GBP2025-03-31
45,316 GBP2024-03-31
Other Creditors
Current
6,058 GBP2025-03-31
1,812 GBP2024-03-31

  • SHALL DERMATOLOGY LIMITED
    Info
    Registered number 08508513
    Middle House, The Green, Offham, Kent ME19 5NN
    PRIVATE LIMITED COMPANY incorporated on 2013-04-29 (13 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-04-29
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.